BCL2A1, reported to act anti-apoptotically, is induced by the transcription factor NF-κB, which controls numerous genes involved in inflammatory diseases, such as atherosclerosis, bowel disease and arthritis44, 53. The gene discussed is BCL2A1; the disease is atherosclerosis.